AAAAAA

   
Results: 1-10 |
Results: 10
COMBINATION CHEMOTHERAPY WITH PACLITAXEL (T) AND EPIRUBICIN (E) FOR METASTATIC BREAST-CANCER (MBC) - A PHASE I-II STUDY
Authors: DURANDO A ALABISO O BELLINO R GENTA F KATSAROS D MALOSSI A AIDALA S MUSSA A MASSOBRIO M
Citation: A. Durando et al., COMBINATION CHEMOTHERAPY WITH PACLITAXEL (T) AND EPIRUBICIN (E) FOR METASTATIC BREAST-CANCER (MBC) - A PHASE I-II STUDY, European journal of cancer, 34, 1998, pp. 41-41
AXILLARY STAGING OF T1-T2 BREAST-CANCER
Authors: SANDRUCCI S SORBA P BELLO W DANESE S ROAGNA R DURANDO A GIANI R AIDALA S CLARA R FILIPPI A PELLERITO R SILVESTRO L CALDERINI P GIARDINA G MASSOBRIO M SISMONDI P BISI G MUSSA A FAVERO G MUSSA GC
Citation: S. Sandrucci et al., AXILLARY STAGING OF T1-T2 BREAST-CANCER, European journal of cancer, 34, 1998, pp. 315-315
RELATIONSHIP BETWEEN ESTROGEN-RECEPTOR (ER) STATUS IN PRIMARY BREAST-CANCER (BC) SPECIMENS AND SERUM CA-15-3 LEVELS AT FIRST RELAPSE OF DISEASE
Authors: TAMPELLINI M GORZEGNO G SAROBBA GM DURANDO A ARESE P MANZIN E CASTIGLIONE F DEMATTEIS A NUZZO F DOGLIOTTI L
Citation: M. Tampellini et al., RELATIONSHIP BETWEEN ESTROGEN-RECEPTOR (ER) STATUS IN PRIMARY BREAST-CANCER (BC) SPECIMENS AND SERUM CA-15-3 LEVELS AT FIRST RELAPSE OF DISEASE, European journal of cancer, 34, 1998, pp. 480-480
P53 AND WAF1 EXPRESSION IN EPITHELIAL OVARIAN-CANCER - PROGNOSTIC ANDPREDICTIVE IMPLICATIONS
Authors: KATSAROS D GENTA F DURANDO A DANESE S RICCHIARDI R LEVESQUE M DIAMANDIS EP MASSOBRIO M
Citation: D. Katsaros et al., P53 AND WAF1 EXPRESSION IN EPITHELIAL OVARIAN-CANCER - PROGNOSTIC ANDPREDICTIVE IMPLICATIONS, European journal of cancer, 34, 1998, pp. 106-106
SEQUENTIAL EPIDOXORUBICIN AND PACLITAXEL AS PRIMARY CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER
Authors: GIARDINA G DANESE S BELLINO R KATSAROS D DESANCTIS C DURANDO A RICHIARDI G ARESE P GENTA F
Citation: G. Giardina et al., SEQUENTIAL EPIDOXORUBICIN AND PACLITAXEL AS PRIMARY CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST-CANCER, Annals of oncology, 9, 1998, pp. 108-108
FLOW-CYTOMETRY IN BREAST-CANCER - PROGNOSTIC AND SURGICAL INDICATIONSOF THE SPARING OF AXILLARY LYMPH-NODE DISSECTION
Authors: ZANON C DURANDO A GEUNA M CLARA R MOBIGLIA A MASSOBRIO M PALESTRO G POURSHAYESTEH A
Citation: C. Zanon et al., FLOW-CYTOMETRY IN BREAST-CANCER - PROGNOSTIC AND SURGICAL INDICATIONSOF THE SPARING OF AXILLARY LYMPH-NODE DISSECTION, American journal of clinical oncology, 21(4), 1998, pp. 392-397
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
FRAGMENT ANALYSIS OF THE P53 GENE IN OVARIAN-TUMORS
Authors: LIANIDOU ES ANGELOPOULOU K KATSAROS D DURANDO A MASSDARIO M DIAMANDIS EP
Citation: Es. Lianidou et al., FRAGMENT ANALYSIS OF THE P53 GENE IN OVARIAN-TUMORS, Clinical biochemistry, 31(7), 1998, pp. 551-553
CARBOPLATIN PLUS ETOPOSIDE REGIMEN IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: DELTETTO F DURANDO A CAMANNI M PESOLA D SBERVEGLIERI M ARESE P MASSOBRIO M
Citation: F. Deltetto et al., CARBOPLATIN PLUS ETOPOSIDE REGIMEN IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of gynaecological oncology, 18(3), 1997, pp. 185-187
PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL
Authors: BERRUTI A ZOLA P BUNIVA T BAU MG FARRIS A SAROBBA MG BOTTINI A TAMPELLINI M DURANDO A DESTEFANIS M MONZEGLIO C MORO G SUSSIO M PERRONI D DOGLIOTTI L
Citation: A. Berruti et al., PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL, Anticancer research, 17(4A), 1997, pp. 2763-2768
Risultati: 1-10 |